Evidence map›Paper›PMID 41148487›Full record

ArticleMolecular biology reports2025

A FSHR missense variant associated with polycystic ovary syndrome in an Iranian family with multiple affected sisters.

Mahtab Behrafigh, Mouness Rahimian, Maryam Afkari, Mona Khosravi-Far, Navid Almadani, Seyed Abolhassan Shahzadeh Fazeli

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Mahtab BehrafighDepartment of Genetics, Faculty of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, ACECR, Tehran, Iran.
Mouness RahimianDepartment of Molecular and Cellular Biology, Faculty of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, ACECR, Tehran, Iran.
Maryam AfkariDepartment of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, P.O. Box: 16635-148, Tehran, Iran.
Mona Khosravi-FarDepartment of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, P.O. Box: 16635-148, Tehran, Iran.
Navid AlmadaniDepartment of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, P.O. Box: 16635-148, Tehran, Iran.
Seyed Abolhassan Shahzadeh FazeliDepartment of Molecular and Cellular Biology, Faculty of Basic Sciences and Advanced Technologies in Biology, University of Science and Culture, ACECR, Tehran, Iran. a.fazeli@usc.ac.ir.ORCID http://orcid.org/0000-0002-0720-2954

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPolycystic ovary syndrome (PCOS) is a common endocrine-metabolic disorder affecting 5-15% of women of reproductive age and is a leading cause of female infertility. It is a complex, multifactorial condition in which genetic factors play a significant role and may affect siblings within a family. Here, we present the case of two infertile sisters from an Iranian family. METHODS AND

resultsTwo sisters with treatment-resistant infertility and a history of PCOS underwent comprehensive genetic evaluation. Whole exome sequencing (WES) was performed on one of the sisters, and identified a missense variant, rs745386710, which is located in exon 5 of the FSHR gene, resulting in the p.L149F substitution. Sanger sequencing confirmed the presence of this variant in the other affected sister. variant interpretation was conducted in accordance with the guidelines of the American College of Medical Genetics and Genomics (ACMG). Structural protein analysis indicated that this variant may reduce protein-protein affinity. Importantly, we provide the first functional evidence for this variant.

conclusionThis variant appears to significantly reduce protein stability and impair binding to follicle-stimulating hormone (FSH) and its receptor (FSHR), which may inhibit follicular maturation and contribute to the pathogenesis of PCOS.

Indexed as

Mutation, MissensePolycystic Ovary SyndromeReceptors, FSHAdultExome SequencingFemaleFollicle Stimulating HormoneGenetic Predisposition to DiseaseHumansInfertility, FemaleIranPedigreeSiblingsFollicle Stimulating HormoneFSHR protein, humanReceptors, FSHFSHR geneFSHR proteinPolycystic ovary syndromeProtein dockingWhole exome sequencing

Identifiers

PMID41148487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.